Vaccinex, Inc. (VCNX)
1.06
+0.31
(+41.33%)
USD |
OTCM |
Sep 08, 16:00
Vaccinex Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2024 | -0.01 |
| September 30, 2024 | -0.0447 |
| June 30, 2024 | -0.0426 |
| March 31, 2024 | 0.0697 |
| December 31, 2023 | -0.1069 |
| September 30, 2023 | -0.0793 |
| June 30, 2023 | -0.8676 |
| March 31, 2023 | 0.1779 |
| December 31, 2022 | 0.0934 |
| September 30, 2022 | 0.0861 |
| June 30, 2022 | 0.0246 |
| March 31, 2022 | 0.0203 |
| December 31, 2021 | 0.0526 |
| September 30, 2021 | 0.0954 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.2139 |
| March 31, 2021 | 4.191 |
| December 31, 2020 | -0.3465 |
| September 30, 2020 | -0.4468 |
| June 30, 2020 | -0.0384 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.0454 |
| March 31, 2018 | -0.057 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |